Adverse drug reactions in older people

Reviews in Clinical Gerontology

Volumn 20, Issue 3, 2010, Pages 246-259

  Tangiisuran, B ^a   Gozzoli, M P ^b   Davies, J G ^c   Rajkumar, C ^c  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b Borgo Trento Verona Hospital   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

adverse drug events; adverse drug reactions; adverse event; drug prescribing; older people

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARDIAC GLYCOSIDE; CYCLOOXYGENASE 2 INHIBITOR; DIGOXIN; DIURETIC AGENT; IBUPROFEN; LEVODOPA; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; THIAZIDE DIURETIC AGENT; THIOPURINE METHYLTRANSFERASE;

ADVERSE DRUG REACTION; AGING; ANXIETY DISORDER; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMPUTER SYSTEM; DIARRHEA; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ERUPTION; DRUG EXCRETION; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL SYMPTOM; GENETIC VARIABILITY; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPERURICEMIA; INCIDENCE; INDUCED HYPOTENSION; INFORMATION TECHNOLOGY; INTERPERSONAL COMMUNICATION; INTERVENTION STUDY; MEDICAL DOCUMENTATION; MEDICATION ERROR; META ANALYSIS; MORBIDITY; NAUSEA; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT MONITORING; PHARMACIST; PHARMACODYNAMICS; POLYPHARMACY; PRESCRIPTION; PREVALENCE; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; RISK REDUCTION; SENESCENCE; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

EID: 77957306863     PISSN: 09592598     EISSN: 14699036     Source Type: Journal    
DOI: 10.1017/S0959259810000171     Document Type: Review

References (96)

1. McBride WG. Thalidomide and congenital abnormalities. Lancet 1961; ii: 1358.
2. Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care - the POLYMED randomised controlled trial. Age Ageing 2007;36:292-97. (Pubitemid 47072323)
3. Lowe CJ, Raynor DK, Purvis J, Farrin A, Hudson J. Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol 2000;50:172-75. (Pubitemid 30612036)
4. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34.
5. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004;140:795-801. (Pubitemid 38623529)
6. World Health Organisation. International Drug Monitoring: The role of the hospital. WHO Tech Rep Ser 1969.
7. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis and management. Lancet 2000;356:1255-59.
8. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE 2009;4: e4439.
9. Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther 2006;31:335-41. (Pubitemid 44060196)
10. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 2004;329:15-19. (Pubitemid 38869995)
11. Rawlins MD, Thompson JW. Pathogenesis of adverse drug reactions. In Textbooks of Adverse Drug Reactions (ed Davies DM). Oxford, Oxford University Press, 1977.
12. Aronson JK, Ferner RE. Joining the DoTS: new approach to classifying adverse drug reactions. BMJ 2003;327:1222-25. (Pubitemid 37465212)
13. Rommers MK, Teepe-Twiss IM, Guchelaar HJ. Preventing adverse drug events in hospital practice: an overview. Pharmacoepidemiol Drug Safety 2007;16:1129-35. (Pubitemid 350020066)
14. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. NEJM 1991;324:377-84.
15. Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Bandolier Extra Evidence-Based Health Care. 2002 (June): pp. 1-15.
16. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002;24:46-54.
17. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16. (Pubitemid 37430324)
18. Azad N, Tierney M, Victor G, Kumar P. Adverse drug events in the elderly population admitted to a tertiary care hospital. J Healthcare Management/American College of Healthcare Executives 2002;47:295-305; discussion. (Pubitemid 35025820)
19. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Int Med J 2001;31:199-205. (Pubitemid 32592646)
20. Hallas J, Haghfelt T, Gram LF, Grodum E, Damsbo N. Drug related admissions to a cardiology department; frequency and avoidability. J Int Med 1990;228:379-84. (Pubitemid 20337482)
21. Cunningham G, Dodd TRP, Grant DJ, McMurdo MET, Michael R, Richards E. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997;26:375-82. (Pubitemid 27448382)
22. Dartnell JG, Anderson RP, Chohan V, Galbraith KJ, Lyon ME, Nestor PJ et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996;164:659-62. (Pubitemid 26172599)
23. Courtman BJ, Stallings SB. Characterization of drug-related problems in elderly patients on admission to a medical ward. Can J Hosp Pharm 1995;48:161-66.
24. Page RL 2nd, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmcother 2006;4:297-305.
25. Gray SL, Sager M, Lestico MR, Jalaluddin M. Adverse drug events in hospitalized elderly. J Gerontol 1998;53: M59-63. (Pubitemid 128763923)
26. Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospitals: a narrative review. Current Drug Safety 2007;2:79-87. (Pubitemid 46723172)
27. Seidl LG, Thornton GF, Cluff LE. Epidemiological studies of adverse drug reactions. Am J Pub Health 1965;55:1170-75.
28. Hurwitz N, Wade OL. Intensive hospital monitoring of adverse reactions to drugs. BMJ 1969;1:531-36.
29. Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996;42:423-29.
30. Simmons C, Georgeson EM, Hill RC. Adverse drug reactions: Can we reduce the risk? Hosp Pharm 1998;33:1568-76. (Pubitemid 30164542)
31. van Kraaij DJ, Haagsma CJ, Go IH, Gribnau FW. Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. Netherland J Med 1994;44:166-73.
32. Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001;38:666-71. (Pubitemid 33131567)
33. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992;21:294-300.
34. Mannesse CK, Derkx FH, de Ridder MA, Man in't Veld AJ, Van Der Cammen TJ. Adverse drug reactions in elderly patients as a contributing factor for hospital admission: cross sectional study. BMJ 1997;315:1057-58.
35. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5. (Pubitemid 28193431)
36. Wester K, Jonsson AK, Spigset O, Druid H, Hagg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 2008;65:573-79. (Pubitemid 351365134)
37. Department of Health. Audit Commission: A Spoonful of Sugar; Medicines management in NHS hospitals. London: Audit Commission, Department of Health; 2001.
38. Buajordet I, Ebbesen J, Erikssen J, Brors O, Hilberg T. Fatal adverse drug events: the paradox of drug treatment. J Int Med 2001;250:327-41. (Pubitemid 32955618)
39. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:30-36.
40. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997;277:307-11. (Pubitemid 27347291)
41. Rothschild JM, Federico FA, Gandhi TK, Kaushal R, Williams DH, Bates DW. Analysis of medication-related malpractice claims: causes, preventability, and costs. Arch Int Med 2002;162:2414-20. (Pubitemid 35340456)
42. El Desoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther 2007;14:488-98.
43. Tangiisuran B, Wright J, Van Der Cammen T, Rajkumar C. Adverse drug reactions in elderly: challenges in identification and improving preventative strategies. Age Ageing 2009;38:358-59.
44. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. Br J Clin Pharmacol 2003;57:6-14.
45. Mannesse CK, Van Der Cammen TJ. [Adverse drug reactions in three older patients, even without changes in medication]. Nederlands tijdschrift voor geneeskunde 2003;147:585-87.
46. Zeeh J, Platt D. The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology 2002;48:121-27. (Pubitemid 34310065)
47. Wang L. Changes in pharmacokinetics in the elderly and therapeutic drug monitoring of antiarrhythmic drugs. Life Sci J 2007;4:1-7.
48. Department of Health. National Service Framework for Older People. London: Department of Health; 2001.
49. Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M et al. Risk factors for adverse drug events among nursing home residents. Arch Int Med 2001;161:1629-34. (Pubitemid 32681144)
50. Nguyen JK, Fouts MM, Kotabe SE, Lo E. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 2006;4:36-41. (Pubitemid 43758180)
51. Veehof LJ, Stewart RE, Meyboom-de Jong B, Haaijer-Ruskamp FM. Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 1999;55:533-36. (Pubitemid 29446555)
52. Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). JAGS 2002;50:1962-68. (Pubitemid 35462441)
53. Zopf Y, Rabe C, Neubert A, Hahn EG, Dormann H. Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf 2008;31:789-98.
54. van den Bemt PM, Egberts AC, Lenderink AW, Verzijl JM, Simons KA, van der Pol WS et al. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 2000;22:62-66. (Pubitemid 30306123)
55. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Int Med 2008;168:1890-96.
56. Campbell SE, Seymour DG, Primrose WR. A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age Ageing 2004;33:110-15.
57. Kennerfalk A, Ruigomez A, Wallander MA, Wilhelmsen L, Johansson S. Geriatric drug therapy and healthcare utilization in the United kingdom. Ann Pharmacother 2002;36:797-803. (Pubitemid 34517406)
58. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D et al. Treatment of hypertension in patients 80 years of age or older. NEJM 2008;358:1887-98. (Pubitemid 351620109)
59. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003;289:1652-58. (Pubitemid 37430270)
60. Juurlink DN, Mamdani MM, Kopp A, Rochon PA, Shulman KI, Redelmeier DA. Drug-induced lithium toxicity in the elderly: a population-based study. JAGS 2004;52:794-98. (Pubitemid 38596502)
61. Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M et al. Systematic overview of warfarin and its drug and food interactions. Arch Int Med 2005;165:1095-106. (Pubitemid 40720733)
62. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997;315:1096-99.
63. Hamilton HJ, Gallagher PF, O'Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr 2009;9:5.
64. Hajjar ER, Hanlon JT, Sloane RJ, Lindblad CI, Pieper CF, Ruby CM et al. Unnecessary drug use in frail older people at hospital discharge. JAGS 2005;53:1518-23. (Pubitemid 41602441)
65. Schneider JK, Mion LC, Frengley JD. Adverse drug reactions in an elderly outpatient population. Am J Hosp Pharm 1992;49:90-96.
66. McElnay JC, McCallion CR, Al-Deagi F, Scott MG. Development of a risk model for adverse drug events in the elderly. Clin Drug Invest 1997;13:47-55. (Pubitemid 27060796)
67. Bowman L, Carlstedt BC, Hancock EF, Black CD. Adverse drug reaction (ADR) occurrence and evaluation in elderly inpatients. Pharmacoepidemiol Drug Safety 1996;5:9-18. (Pubitemid 26094483)
68. Vakil BJ, Kulkarni RD, Chabria NL, Chadha DR, Deshpande VA. Intense surveillance of adverse drug reactions. An analysis of 338 patients. J Clin Pharmacol 1975;15:435-41.
69. Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacol 2003;1:82-89.
70. Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 2007;5:31-39.
71. Ganjavi H, Herrmann N, Rochon PA, Sharma P, Lee M, Cassel D et al. Adverse drug events in cognitively impaired elderly patients. Dem Geriatr Cog Disord 2007;23:395-400. (Pubitemid 46897176)
72. Onder G, Gambassi G, Scales CJ, Cesari M, Vedova CD, Landi F et al. Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol 2002;58:371-77. (Pubitemid 34983929)
73. Hallas J, Worm J, Beck-Nielsen J, Gram LF, Grodum E, Damsbo N et al. Drug related events and drug utilization in patients admitted to a geriatric hospital department. Dan Med Bull 1991;38:417-20.
74. Mannesse CK, Derkx FH, de Ridder MA, Man in't Veld AJ, Van Der Cammen TJ. Do older hospital patients recognize adverse drug reactions? Age Ageing 2000;29:79-81. (Pubitemid 30055069)
75. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007;63:136-47. (Pubitemid 46072098)
76. Reason J. Human error: models and management. BMJ 2000;320:768-70. (Pubitemid 30179429)
77. Pham CB, Dickman RL. Minimizing adverse drug events in older patients. Am Fam Physician 2007;76:1837-44.
78. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995;274:35-43.
79. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Int Med 2003;163:1409-16. (Pubitemid 36758913)
80. Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998;280:1311-16. (Pubitemid 28473716)
81. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Int Med 2003;163:2014-18. (Pubitemid 37151242)
82. Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2008;65:303-16. (Pubitemid 351316922)
83. Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Int Med 2009;169:894-900.
84. Schmader KE, Hanlon JT, Pieper CF, Sloane R, Ruby CM, Twersky J et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004;116:394-401. (Pubitemid 38299484)
85. Andersohn F, Suissa S, Garbe E. Use of first-and second-generation cyclooxygenase-2-selective non-steroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation 2006;113:1950-57. (Pubitemid 43754197)
86. Ayers CR, Sorrell JT, Thorp SR, Wetherell JL. Evidence-based psychological treatments for late-life anxiety. Psychology Aging 2007;22:8-17. (Pubitemid 46494612)
87. Meyer UA. Pharmacogenetics and adverse drug reactions. Lancet 2000;356:1667-71.
88. Ross CJ, Katzov H, Carleton B, Hayden MR. Pharmacogenomics and its implications for autoimmune disease. J Autoimmun 2007;28:122-28. (Pubitemid 46670689)
89. Steyerberg E. Clinical Prediction Models: A practical approach to development, validation, and updating. Gail MKK, Samet J, Tsiatis A, Wong W (eds). Rotterdam: Springer; 2009.
90. Wasson JH, Sox HC, Neff RK, Goldman L. Clinical prediction rules. Applications and methodological standards. NEJM 1985;313:793-99. (Pubitemid 15232315)
91. Johnston PE, France DJ, Byrne DW, Murff HJ, Lee B, Stiles RA et al. Assessment of adverse drug events among patients in a tertiary care medical center. Am J Health Syst Pharm 2006;63:2218-27. (Pubitemid 44851435)
92. Rask KJ, Wells KJ, Teitel GS, Hawley JN, Richards C, Gazmararian JA. Can an algorithm for appropriate prescribing predict adverse drug events? Am J Man Care 2005;11:145-51. (Pubitemid 40387637)
93. Passarelli MC, Jacob-Filho W. Adverse drug reactions in elderly patients: how to predict them? Einstein 2007;5:246-51.
94. Onder G, Petrovic M, Tangiisuran B, Meinardi MC, Markito-Notenboorn WP, Somers A et al. Development and validation of a score to assess risk of adverse drug reactions among inhospital patients aged 65 or older: The Geronto net ADR risk score. Arch Int Med 2010 (in press).
95. Elnicki RA, Schmitt JP. Contribution of patient and hospital characteristics to adverse patient incidents. Health Serv Res 1980;15:397-414.
96. Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 2003;60:1750-59. (Pubitemid 44717415)